- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00578383
Low Field Magnetic Stimulation in Mood Disorders Using the LFMS Device (LFMS)
April 12, 2016 updated by: Michael Rohan, Mclean Hospital
This study is designed to test whether low-field magnetic stimulation (LFMS) can relieve some of the symptoms of depression in bipolar disorder or major depression.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
This study involves a screening visit with the study physician and a treatment visit.
Participants will be asked to complete several questionnaires about their mood during both visits.
The treatment visit will involve use of the LFMS device.
Participants will place the top of their head inside the device for approximately 20 minutes.
Participants will receive either the actual treatment or a sham treatment and will not know which they receive.
This device produces weak electromagnetic fields.
There is no discomfort or even sensation caused by the device.
The device has been declared to be a "non-significant risk device" by the FDA, and there are no known risks associated with its use.
Study Type
Interventional
Enrollment (Actual)
107
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Massachusetts
-
Belmont, Massachusetts, United States, 02478
- McLean Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Diagnosis of Major Depressive Disorder or Bipolar Disorder; must be currently depressed
- May be medicated or unmedicated
Exclusion Criteria:
- Contraindication for MRI due to metal in eyes/head
- Claustrophobia.
- Inability to lie flat.
- History of brain injury.
- Pregnant
- Current drug use/abuse/dependence
- History of polysubstance use
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Sham Comparator: Sham (inactive) Treatment BPD
20 minutes of sham treatment with the Low Field Magnetic Stimulation Device (LFMS)in bipolar depressed subjects
|
The LFMS Device is an electromagnetic coil situated on a cylinder with an inside diameter of 13.2 inches.
It produces weak electromagnetic fields at a frequency of about 1 kHz; the magnetic fields are less than 30 Gauss and the electric fields are up to 1.43 V/m.
Subjects will receive one 20 minute treatment.
Other Names:
|
Active Comparator: Active LFMS treatment in BPD
20 minutes of active treatment with the Low Field Magnetic Stimulation Device (LFMS)in bipolar depressed subjects
|
The LFMS Device is an electromagnetic coil situated on a cylinder with an inside diameter of 13.2 inches.
It produces weak electromagnetic fields at a frequency of about 1 kHz; the magnetic fields are less than 30 Gauss and the electric fields are up to 1.43 V/m.
Subjects will receive one 20 minute treatment.
Other Names:
|
Sham Comparator: Sham LFMS Comparator: in MD
20 minutes of sham treatment with the Low Field Magnetic Stimulation Device (LFMS) in major depressed subjects
|
The LFMS Device is an electromagnetic coil situated on a cylinder with an inside diameter of 13.2 inches.
It produces weak electromagnetic fields at a frequency of about 1 kHz; the magnetic fields are less than 30 Gauss and the electric fields are up to 1.43 V/m.
Subjects will receive one 20 minute treatment.
Other Names:
|
Active Comparator: Experimental LFMS: in MD
20 minutes of active treatment with the Low Field Magnetic Stimulation Device (LFMS) in major depressed subjects
|
The LFMS Device is an electromagnetic coil situated on a cylinder with an inside diameter of 13.2 inches.
It produces weak electromagnetic fields at a frequency of about 1 kHz; the magnetic fields are less than 30 Gauss and the electric fields are up to 1.43 V/m.
Subjects will receive one 20 minute treatment.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mean Change in Hamilton Depression Rating Scale (HAM-D) (17 Item) in Subjects With Bipolar Depression
Time Frame: Once just before and once just after treatment
|
A multiple choice questionnaire used to rate depression severity.
Mean change from pretreatment score.
17 items reflecting depression symptoms are scored on scale of severity; 9 items are scored 0 = Absent 1 = Trivial 2 = Mild 3 = Moderate 4 = Severe 8 items are scored 0 = Absent 1 = Mild 2 = Severe.
Items are summed; minimum score is 0, maximum score is 52.
Higher scores represent more severe depression.
|
Once just before and once just after treatment
|
Mean Change in Hamilton Depression Depression Rating Scale (HAM-D) (17 Item) in Subjects With Major Depressive Disorder
Time Frame: Once just before and once just after treatment
|
A multiple choice questionnaire used to rate depression severity.
Mean change from pretreatment score.
17 items reflecting depression symptoms are scored on scale of severity; 9 items are scored 0 = Absent 1 = Trivial 2 = Mild 3 = Moderate 4 = Severe 8 items are scored 0 = Absent 1 = Mild 2 = Severe.
Items are summed; minimum score is 0, maximum score is 52.
Higher scores represent more severe depression.
|
Once just before and once just after treatment
|
Visual Analog Scale (VAS) in Subjects With Bipolar Depression
Time Frame: Once just before and once just after treatment
|
Eleven point Likert scales indicating immediate depression state.
Mean change from pretreatment score.
Participant marks an 'X' on a numbered line anchored by 0 = no depression and 10 = most depressed ever been.
|
Once just before and once just after treatment
|
Visual Analog Scale (VAS) in Subjects With Major Depressive Disorder
Time Frame: Once just before and once just after treatment
|
Eleven point Likert scales indicating immediate depression state.
Mean change from pretreatment score.
Participant marks an 'X' on a numbered line anchored by 0 = no depression and 10 = most depressed ever been.
|
Once just before and once just after treatment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mean Change in Hamilton Depression Rating Scale (HAM-D) (17 Item): Combined Diagnostic Groups.
Time Frame: Once just before and once just after treatment
|
A multiple choice questionnaire used to rate depression severity.
Mean change from pretreatment score.
17 items reflecting depression symptoms are scored on scale of severity; 9 items are scored 0 = Absent 1 = Trivial 2 = Mild 3 = Moderate 4 = Severe 8 items are scored 0 = Absent 1 = Mild 2 = Severe.
Items are summed; minimum score is 0, maximum score is 52.
Higher scores represent more severe depression.
|
Once just before and once just after treatment
|
Visual Analog Scale (VAS): Combined Diagnostic Groups.
Time Frame: Once just before and once just after treatment
|
Eleven point Likert scales indicating immediate depression state.
Mean change from pretreatment score.
Participant marks an 'X' on a numbered line anchored by 0 = no depression and 10 = most depressed ever been.
|
Once just before and once just after treatment
|
Positive and Negative Affect Schedule (PANAS) Positive Score: Combined Diagnostic Group.
Time Frame: Once just before and once just after treatment
|
20 item list of words that describe different feelings and emotions with positive and negative valences (10 each), which the subject scores on a 1-5 scale: 1 = very slightly or not at all 2 = a little 3 = moderate 4 = quite a bit 5 = extremely.
Positive and Negative scores are calculated and reported separately and range from 10-50.
Higher positive score reflects stronger positive affect and higher negative score reflects stronger negative affect.
|
Once just before and once just after treatment
|
Positive and Negative Affect Schedule (PANAS) Negative Score: Combined Diagnostic Group.
Time Frame: once pre and once post LFMS treatment
|
20 item list of words that describe different feelings and emotions with positive and negative valences (10 each), which the subject scores on a 1-5 scale: 1 = very slightly or not at all 2 = a little 3 = moderate 4 = quite a bit 5 = extremely.
Positive and Negative scores are calculated and reported separately and range from 10-50.
Higher positive score reflects stronger positive affect and higher negative score reflects stronger negative affect.
|
once pre and once post LFMS treatment
|
Positive and Negative Affect Schedule (PANAS) Positive Score in Subjects With Bipolar Depression.
Time Frame: Once just before and once just after treatment
|
20 item list of words that describe different feelings and emotions with positive and negative valences (10 each), which the subject scores on a 1-5 scale: 1 = very slightly or not at all 2 = a little 3 = moderate 4 = quite a bit 5 = extremely.
Positive and Negative scores are calculated and reported separately and range from 10-50.
Higher positive score reflects stronger positive affect and higher negative score reflects stronger negative affect.
|
Once just before and once just after treatment
|
Positive and Negative Affect Schedule (PANAS) Positive Score in Subjects With Major Depressive Disorder
Time Frame: Once just before and once just after treatment
|
20 item list of words that describe different feelings and emotions with positive and negative valences (10 each), which the subject scores on a 1-5 scale: 1 = very slightly or not at all 2 = a little 3 = moderate 4 = quite a bit 5 = extremely.
Positive and Negative scores are calculated and reported separately and range from 10-50.
Higher positive score reflects stronger positive affect and higher negative score reflects stronger negative affect.
|
Once just before and once just after treatment
|
Positive and Negative Affect Schedule (PANAS) Negative Score in Subjects With Bipolar Depression
Time Frame: once pre and once post LFMS treatment
|
20 item list of words that describe different feelings and emotions with positive and negative valences (10 each), which the subject scores on a 1-5 scale: 1 = very slightly or not at all 2 = a little 3 = moderate 4 = quite a bit 5 = extremely.
Positive and Negative scores are calculated and reported separately and range from 10-50.
Higher positive score reflects stronger positive affect and higher negative score reflects stronger negative affect.
|
once pre and once post LFMS treatment
|
Positive and Negative Affect Schedule (PANAS) Negative Score in Subjects With Major Depressive Disorder
Time Frame: once pre and once post LFMS treatment
|
20 item list of words that describe different feelings and emotions with positive and negative valences (10 each), which the subject scores on a 1-5 scale: 1 = very slightly or not at all 2 = a little 3 = moderate 4 = quite a bit 5 = extremely.
Positive and Negative scores are calculated and reported separately and range from 10-50.
Higher positive score reflects stronger positive affect and higher negative score reflects stronger negative affect.
|
once pre and once post LFMS treatment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Michael Rohan, PhD, McLean Hospital
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Carlezon WA Jr, Rohan ML, Mague SD, Meloni EG, Parsegian A, Cayetano K, Tomasiewicz HC, Rouse ED, Cohen BM, Renshaw PF. Antidepressant-like effects of cranial stimulation within a low-energy magnetic field in rats. Biol Psychiatry. 2005 Mar 15;57(6):571-6. doi: 10.1016/j.biopsych.2004.12.011.
- Rohan M, Parow A, Stoll AL, Demopulos C, Friedman S, Dager S, Hennen J, Cohen BM, Renshaw PF. Low-field magnetic stimulation in bipolar depression using an MRI-based stimulator. Am J Psychiatry. 2004 Jan;161(1):93-8. doi: 10.1176/appi.ajp.161.1.93.
- Rohan ML, Yamamoto RT, Ravichandran CT, Cayetano KR, Morales OG, Olson DP, Vitaliano G, Paul SM, Cohen BM. Rapid mood-elevating effects of low field magnetic stimulation in depression. Biol Psychiatry. 2014 Aug 1;76(3):186-93. doi: 10.1016/j.biopsych.2013.10.024. Epub 2013 Nov 12.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2007
Primary Completion (Actual)
March 1, 2011
Study Completion (Actual)
March 1, 2013
Study Registration Dates
First Submitted
December 18, 2007
First Submitted That Met QC Criteria
December 18, 2007
First Posted (Estimate)
December 21, 2007
Study Record Updates
Last Update Posted (Estimate)
May 16, 2016
Last Update Submitted That Met QC Criteria
April 12, 2016
Last Verified
April 1, 2016
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2006-P-001655
- Stanley Grant 07TGS-1045 (Other Grant/Funding Number: Stanley Grant 07TGS-1045)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
ProgenaBiomeRecruitingDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of California, San FranciscoRecruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
University GhentUniversiteit Antwerpen; Janssen-Cilag Ltd.RecruitingDepression Moderate | Depression Severe | Depression MildBelgium
-
Baylor College of MedicineUniversity of TexasRecruitingDepression | Depression Moderate | Depression Severe | Suicide and Self-harm | Depression in Adolescence | Depression MildUnited States
-
University of Cape TownNational Institute of Mental Health (NIMH)CompletedPostpartum Depression | Clinical Depression | Moderate DepressionSouth Africa
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; National Institute of Mental...CompletedMajor Depressive Disorder | Treatment Resistant Depression | Treatment-Refractory Depression | Late Life Depression | Geriatric DepressionUnited States, Canada
-
Northern Illinois UniversityUniversity Autonoma de Santo DomingoTerminatedDepression Moderate | Depression MildUnited States, Dominican Republic
-
Gerbera Therapeutics, Inc.Not yet recruitingPostpartum Depression | Depression, Postpartum | Postnatal Depression | Post-partum Depression | Post-Natal DepressionUnited States
Clinical Trials on Low Field Magnetic Stimulation Device
-
Mclean HospitalSuspendedBipolar Depression | Unipolar DepressionUnited States
-
Weill Medical College of Cornell UniversityCompletedTreatment Resistant DepressionUnited States
-
Mclean HospitalTerminatedBipolar Depression Depressed PhaseUnited States
-
Tal Medical, Inc.CompletedDepressive Disorder | Depression | Depressive Disorder, Major | Depressive Disorder, Treatment-resistantUnited States
-
Mclean HospitalThe Depressive and Bipolar Disorder Alternative Treatment FoundationCompletedBipolar DepressionUnited States
-
Mclean HospitalUnknown
-
Mclean HospitalUnknownPost Traumatic Stress DisorderUnited States
-
Elias ManjarrezNational Council of Science and Technology, MexicoActive, not recruitingCOVID-19 | Oxygen Deficiency | Acute Respiratory FailureMexico
-
Mclean HospitalStanley Medical Research InstituteTerminatedDepression | Bipolar Disorder | Bipolar DepressionUnited States
-
Mclean HospitalActive, not recruitingBipolar Disorder | Bipolar Depression | Bipolar I Disorder | Bipolar II DisorderUnited States